Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study). (Q41927831)

14 October 2017

title

Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study). (English)

1 reference

multicenter clinical trial

14 October 2017

main subject

0 references

1 reference

26

1 reference

Nathalie Costedoat-Chalumeau

14 October 2017

1

Nathalie Costedoat-Chalumeau

1 reference

14 October 2017

Frédéric Lioté

6

0 references

Patrice Cacoub

Patrice Cacoub

21

0 references

Zahir Amoura

29

Zahir Amoura

1 reference

14 October 2017

30

Jean-Charles Piette

1 reference

14 October 2017

2

Lionel Galicier

1 reference

14 October 2017

22

Moez Jallouli

1 reference

14 October 2017

25

Marie-Laure Tanguy

1 reference

14 October 2017

3

Olivier Aumaître

1 reference

14 October 2017

5

Véronique Le Guern

1 reference

14 October 2017

8

Nicolas Limal

1 reference

14 October 2017

9

Laurent Perard

1 reference

14 October 2017

Hélène Desmurs-Clavel

10

Hélène Desmurs-Clavel

1 reference

14 October 2017

12

Bouchra Asli

1 reference

14 October 2017

13

Jean-Emmanuel Kahn

1 reference

14 October 2017

15

Laurent Sailler

1 reference

14 October 2017

18

Karim Sacré

1 reference

14 October 2017

19

Olivier Fain

1 reference

14 October 2017

24

Judith Cohen-Bittan

1 reference

14 October 2017

27

Philippe Lechat

1 reference

14 October 2017

28

Lucile Musset

1 reference

14 October 2017

Du Le Thi Huong Boutin

11

Du Le Thi Huong Boutin

1 reference

14 October 2017

23

Gaelle Leroux

1 reference

14 October 2017

14

Jacques Pourrat

1 reference

14 October 2017

Camille Francès

4

1 reference

14 October 2017

Amar Smail

7

1 reference

14 October 2017

Félix Ackermann

16

1 reference

14 October 2017

Thomas Papo

17

1 reference

14 October 2017

Jerome Stirnemann

20

1 reference

14 October 2017

Group PLUS

31

1 reference

14 October 2017

language of work or name

English

0 references

publication date

10 November 2012

1 reference

Annals of the Rheumatic Diseases

14 October 2017

published in

1 reference

14 October 2017

volume

72

1 reference

14 October 2017

issue

11

1 reference

14 October 2017

page(s)

1786-1792

1 reference

Systemic lupus erythematosus.

14 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202322

Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202322

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202322

A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202322

Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202322

Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202322

Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: a French multicenter prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202322

Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202322

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202322

Combined oral contraceptives in women with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202322

Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202322

Usefulness of cellular text messaging for improving adherence among adolescents and young adults with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202322

Comparison of drug adherence rates among patients with seven different medical conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202322

Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202322

The role of autophagy in cancer: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202322

Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202322

The role of autophagy in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202322

10.1136/ANNRHEUMDIS-2012-202322

21 January 2018

Identifiers

DOI

1 reference

14 October 2017

1 reference